These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25569440)

  • 21. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.
    Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B
    Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions.
    Fanen P; Ghanem N; Vidaud M; Besmond C; Martin J; Costes B; Plassa F; Goossens M
    Genomics; 1992 Jul; 13(3):770-6. PubMed ID: 1379210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
    J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation characterization of CFTR gene in 206 Northern Irish CF families: thirty mutations, including two novel, account for approximately 94% of CF chromosomes.
    Hughes DJ; Hill AJ; Macek M; Redmond AO; Nevin NC; Graham CA
    Hum Mutat; 1996; 8(4):340-7. PubMed ID: 8956039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations.
    Kambouris M; Banjar H; Moggari I; Nazer H; Al-Hamed M; Meyer BF
    Eur J Pediatr; 2000 May; 159(5):303-9. PubMed ID: 10834512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.
    Will K; Dörk T; Stuhrmann M; Meitinger T; Bertele-Harms R; Tümmler B; Schmidtke J
    J Clin Invest; 1994 Apr; 93(4):1852-9. PubMed ID: 7512993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 99% of CFTR gene mutations in Bulgarian-, Bulgarian Turk-, and Roma cystic fibrosis patients.
    Petrova G; Yaneva N; Hrbková J; Libik M; Savov A; Macek M
    Mol Genet Genomic Med; 2019 Aug; 7(8):e696. PubMed ID: 31245908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Diagnostics of Cystic Fibrosis in Serbia: Our Approach to Meet the Diagnostic Challenges.
    Divac Rankov A; Kusic-Tisma J; Ljujic M; Nikolic A; Milosevic K; Vilotijevic Dautovic G; Radojkovic D
    Genet Test Mol Biomarkers; 2020 Apr; 24(4):212-216. PubMed ID: 32286879
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.
    Highsmith WE; Burch LH; Zhou Z; Olsen JC; Boat TE; Spock A; Gorvoy JD; Quittel L; Friedman KJ; Silverman LM
    N Engl J Med; 1994 Oct; 331(15):974-80. PubMed ID: 7521937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization and phenotypic spectrum of three recurrent disease-causing deep intronic variants of the CFTR gene.
    Bergougnoux A; Délétang K; Pommier A; Varilh J; Houriez F; Altieri JP; Koenig M; Férec C; Claustres M; Lalau G; Bienvenu T; Audrézet MP; Pagin A; Girodon E; Raynal C; Taulan-Cadars M
    J Cyst Fibros; 2019 Jul; 18(4):468-475. PubMed ID: 30389601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations.
    Nissim-Rafinia M; Chiba-Falek O; Sharon G; Boss A; Kerem B
    Hum Mol Genet; 2000 Jul; 9(12):1771-8. PubMed ID: 10915765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of CFTR mutations in cystic fibrosis patients of Tunisian origin: identification of two novel mutations.
    Messaoud T; Verlingue C; Denamur E; Pascaud O; Quéré I; Fattoum S; Elion J; Férec C
    Eur J Hum Genet; 1996; 4(1):20-4. PubMed ID: 8800923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.
    Sheridan MB; Hefferon TW; Wang N; Merlo C; Milla C; Borowitz D; Green ED; Mogayzel PJ; Cutting GR
    J Med Genet; 2011 Apr; 48(4):235-41. PubMed ID: 21097845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening.
    Hantash FM; Redman JB; Starn K; Anderson B; Buller A; McGinniss MJ; Quan F; Peng M; Sun W; Strom CM
    Hum Genet; 2006 Mar; 119(1-2):126-36. PubMed ID: 16362824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The suppression of premature termination codons and the repair of splicing mutations in CFTR.
    Oren YS; Pranke IM; Kerem B; Sermet-Gaudelus I
    Curr Opin Pharmacol; 2017 Jun; 34():125-131. PubMed ID: 29128743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
    Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
    Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy.
    Devoto M; Ronchetto P; Fanen P; Orriols JJ; Romeo G; Goossens M; Ferrari M; Magnani C; Seia M; Cremonesi L
    Am J Hum Genet; 1991 Jun; 48(6):1127-32. PubMed ID: 1709778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Splicing modulation as a modifier of the CFTR function.
    Nissim-Rafinia M; Kerem B
    Prog Mol Subcell Biol; 2006; 44():233-54. PubMed ID: 17076271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis families.
    Dörk T; Neumann T; Wulbrand U; Wulf B; Kälin N; Maass G; Krawczak M; Guillermit H; Ferec C; Horn G
    Hum Genet; 1992 Feb; 88(4):417-25. PubMed ID: 1371263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.